Show simple item record

dc.contributor.authorZaidi, S N
dc.contributor.authorLaidlaw, Ian
dc.contributor.authorHowell, Anthony
dc.contributor.authorPotten, Christopher S
dc.contributor.authorCooper, Donald P
dc.contributor.authorO'Connor, Peter J
dc.date.accessioned2010-08-16T14:41:06Z
dc.date.available2010-08-16T14:41:06Z
dc.date.issued1992-07
dc.identifier.citationNormal human breast xenografts activate N-nitrosodimethylamine: identification of potential target cells for an environmental nitrosamine. 1992, 66 (1):79-83 Br. J. Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid1637681
dc.identifier.urihttp://hdl.handle.net/10541/109659
dc.description.abstractNormal human breast tissue maintained as xenografts in female Balb/c (nu/nu) athymic mice is capable of metabolising N-nitrosodimethylamine (NDMA) to active intermediates that will react with DNA. Administration of NDMA to mice with slow-release implants of 17 beta-oestradiol which provide human physiological (luteal phase) circulating oestrogen levels and increase cell proliferation in the xenograft (Laidlaw et al., 1992), leads to an apparent increase in the extent of reaction with DNA compared to controls without oestrogen implants. In mice with oestrogen implants, measurements of the amounts of the promutagenic lesion, O6-methyl-2'-deoxyguanosine formed in DNA clearly indicated a dose related increase in the extent of reaction. Detection of O6-methyl-2'-deoxyguanosine using immunohistochemical procedures revealed that the nuclei of cells of the glandular epithelium, supportive tissue and adipose tissue, in decreasing order of prevalence, were positively stained for the presence of this DNA lesion. Epithelial cells, which are the putative target cells for carcinogenesis in the breast, are therefore prone to promutagenic damage as a result of exposure to an environmental nitrosamine.
dc.language.isoenen
dc.subject.meshAnimals
dc.subject.meshBiotransformation
dc.subject.meshBreast
dc.subject.meshDNA
dc.subject.meshDeoxyguanosine
dc.subject.meshDimethylnitrosamine
dc.subject.meshDrug Implants
dc.subject.meshEstradiol
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunohistochemistry
dc.subject.meshMice
dc.subject.meshMice, Nude
dc.subject.meshTransplantation, Heterologous
dc.titleNormal human breast xenografts activate N-nitrosodimethylamine: identification of potential target cells for an environmental nitrosamine.en
dc.typeArticleen
dc.contributor.departmentDepartment of Carcinogenesis, Christie Hospital (NHS) Trust, Manchester, UK.en
dc.identifier.journalBritish Journal of Canceren
html.description.abstractNormal human breast tissue maintained as xenografts in female Balb/c (nu/nu) athymic mice is capable of metabolising N-nitrosodimethylamine (NDMA) to active intermediates that will react with DNA. Administration of NDMA to mice with slow-release implants of 17 beta-oestradiol which provide human physiological (luteal phase) circulating oestrogen levels and increase cell proliferation in the xenograft (Laidlaw et al., 1992), leads to an apparent increase in the extent of reaction with DNA compared to controls without oestrogen implants. In mice with oestrogen implants, measurements of the amounts of the promutagenic lesion, O6-methyl-2'-deoxyguanosine formed in DNA clearly indicated a dose related increase in the extent of reaction. Detection of O6-methyl-2'-deoxyguanosine using immunohistochemical procedures revealed that the nuclei of cells of the glandular epithelium, supportive tissue and adipose tissue, in decreasing order of prevalence, were positively stained for the presence of this DNA lesion. Epithelial cells, which are the putative target cells for carcinogenesis in the breast, are therefore prone to promutagenic damage as a result of exposure to an environmental nitrosamine.


This item appears in the following Collection(s)

Show simple item record